© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Fenofibrate brings its own spot in the world of chemical compounds, widely used to manage cholesterol by lowering LDL and triglyceride levels. It often appears as a raw material in the pharmaceutical industry, mostly known in both solid and crystalline forms. Here’s a compound that doesn’t just hide behind a formula—C20H21ClO4—it stands out for its clear clinical utility and its specific physical nature.
This compound takes solid form at room temperature, with a distinct crystalline appearance. Often described as white to off-white flakes or powder, fenofibrate generally does not dissolve easily in water, but it breaks down better in organic solvents like ethanol or acetone. Its density lands close to 1.2 grams per cubic centimeter, marking it as neither feathery nor particularly heavy by laboratory handling standards. That crystalline structure sets the groundwork for its physical resilience—the material holds up well under typical storage conditions, though it prefers cool and dry storage for its longevity.
Fenofibrate's structure connects a benzophenone backbone with an isopropyl ester. This arrangement fuels its role in drug design, targeting fatty acid metabolism in the liver. Its molecular weight clocks in around 360.83 g/mol, which sits right in the expected range for pharmaceuticals built for oral use. C20H21ClO4 stands as the molecular formula, expressing carbon, hydrogen, chlorine, and oxygen in a precise arrangement. The presence of chlorine in its makeup—an atom not seen in many over-the-counter compounds—calls for proper chemical handling, especially for those mixing raw materials or scaling up production.
Manufacturers often provide fenofibrate in several forms: powder, flakes, sometimes even pearlescent grains or crystalline slabs. Each has its own reason for appearing. Powder suits fine-mixing for tablet production, flakes fit bulk shipping or blending, and pearls pop up in applications needing controlled dissolution rates. These forms all trace their source material back to the same core molecular structure, but the process of manufacturing and refining produces these differences, meeting specific handling needs in the supply chain.
Working with fenofibrate, solubility stands as a key property. Water alone struggles to break it down, which means pharmaceutical companies often turn to organic solvents or craft specialized solutions for dosing. In the manufacturing process, controlling this property matters for both consistency and dosage accuracy. Anyone who’s ever worked in a lab knows the frustration of a clumpy, half-dissolved powder. Solving that calls for the right solvent choice, precise measurements, and careful conditions—not blind trial and error.
In the global marketplace, fenofibrate falls under the HS Code 29333990, captured among other heterocyclic compounds. Import regulations in different countries treat it as a controlled raw material because of its role in the pharmaceutical sector. Safety information shows that fenofibrate should be handled with care, as it can pose hazards by inhalation or contact in raw form; gloves, goggles, and good ventilation aren’t optional—they’re expected. Chronic exposure or poor handling has led to harmful side effects in the past, including skin irritation and respiratory distress among workers in poorly ventilated spaces. Chemical handling isn’t just about ticking compliance boxes—workplace safety means keeping real people healthy and on the job.
Pharmaceutical companies draw fenofibrate from a tightly-regulated supply chain—checked not only for purity but also for sourcing transparency. Purity matters for drug efficacy and, ultimately, for patient health. The industry keeps a close eye on certificate of analysis with every batch, checking solubility, density, residual solvents, and particulate size. Sourcing fenofibrate from reputable suppliers makes the difference in both production cost and end-user safety. Subpar material doesn’t just cost money in recalls—it costs trust, which is much harder to regain.
Work within the chemical and pharmaceutical industries has taught many professionals the pain points of working with raw materials like fenofibrate. Static buildup leads to powder floating off during weighing. Fine particles get everywhere unless you’ve got a cleanroom with a proper filtration system. Temperature swings in the warehouse clump up bags of flakes, wasting material and time. Solutions here come from investment in climate control, proper containerization, anti-static devices, and obsessive training in handling protocols. These create an environment where the compound can be weighed, mixed, and packed into finished products without loss or contamination.
Consistent quality in fenofibrate describes more than a technical standard; for patients relying on cholesterol-lowering drugs, it stands as a safety issue. Regulatory agencies like the FDA, EMA, and counterparts in Asia track every shipment, insisting on testing that proves the compound’s purity and identity. Some years ago, failures in chemical supply chains—contamination scandals—sparked massive recalls around the globe. Now, regulatory agencies maintain databases of approved manufacturers, with random spot checks, production audits, and mandatory reporting. These requirements may slow down suppliers, but they produce confidence at every step, from raw material broker to breakfast-table pill.
Fenofibrate does not escape environmental scrutiny. As a chemical compound, its production leaves a mark—solvents, byproducts, and waste that could pollute water if improperly managed. The industry’s shift toward greener chemistry makes a difference; recycling solvents, filtering residues, and adopting closed systems for chemical reactions cut down waste and improve both efficiency and public image. Proper disposal protocols—high-temperature incineration for waste, strict tracking of effluents—help keep hazardous chemicals away from groundwater. Sustainable practice in material synthesis and use redefines what responsibility looks like in a world facing climate stress and regulatory crackdowns.
Fenofibrate’s place in managing metabolic health issues—especially in patients with high cardiovascular risk—makes it an indispensable raw material in medicine cabinets worldwide. Doctors prescribe it with statins, or as a solo act, for millions struggling with cholesterol. Its safety profile compares favorably to alternatives, with decades of clinical study to back up its reliability. For a compound that starts as a granular raw material, fenofibrate ends up holding the line on everything from heart attack rates to stroke prevention statistics. Stories behind the production—factory workers, truck drivers, laboratory analysts—create the backbone of supply, safety, and trust in every finished dose.
